Blood Transfusion Market Scope
A blood transfusion occurs when blood and blood products are taken and transfused intravenously into one's circulation. Medical devices used in the collection, processing, separation, and storage of blood and blood products are known as blood transfusion devices. The revenue of blood transfusion goods is added to calculate the worldwide blood transfusion market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
High Growth Market | Asia Pacific |
Largest Market | North America |
Unit | Value (USD Million) |
Key Companies Profiled | Immucor Inc. (United States), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Grifols SA (Spain), Kaneka Corporation (Japan) and Fresenius Kabi (Germany) |
CAGR | % |
Blood transfusion is a highly competitive market with a number of big competitors. Mid-size to smaller businesses, on the other hand, are expanding their market presence by releasing new items at cost-effective prices, thanks to technology improvements and product innovation. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Blood Transfusion market throughout the predicted period.
Immucor Inc. (United States), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Grifols SA (Spain), Kaneka Corporation (Japan) and Fresenius Kabi (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Haemonetics Corporation (United States) and Macopharma SA (France).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Blood Transfusion market by Type and Region with country level break-up.
On the basis of geography, the market of Blood Transfusion has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2023. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement.
Market Leaders and their expansionary development strategies
In May 2021, BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its board of directors has unanimously authorized management to proceed with a plan to spin off the company's Diabetes Care business as an independent, publicly-traded company
In February 2024, AABB is pleased to announce the launch of the new AABB Global Transfusion Webcast. The webcast series, which will focus on basic concepts of global transfusion medicine issues, will be hosted by Daniela Hermelin, MD, CABP, chief medical officer of ImpactLife, assistant professor of pathology at Saint Louis School of Medicine, and chair of the AABB Social Media Committee
Blood transfusion services in India are regulated by the Drugs and Cosmetics Act, 1940 and its subsequent amendments. The Drugs and Cosmetics Act, 1940 specifies about accommodation, manpower, equipment, supplies and reagents, good manufacturing practices, and process control to be followed in Indian blood transfusion services.Regulatory affairs in the Indian blood banking system are controlled by central and provincial Drug Control authority under Drug Controller General of India.
Influencing Trend:
Increasing Number of Surgical Procedures and Rise in the Number of Blood Disorders
Market Growth Drivers:
The Increasing Adoption of The Pathogen Reduction System and Increasing Accidents and Trauma Cases
Challenges:
High Costs Associated with Handling of Blood and its Components
Restraints:
Stringent Regulatory Framework
Opportunities:
Increasing Infrastructure Developments in Developing Countries and Increasing Service Efficiency
Key Target Audience
Heath care Software, Government Regulatory Bodies, Private Research Organization, Government Research Organization and Others